Additional Xiaflex Treatment in Patients With Peyronie's Disease Recurrence Worsening or Incomplete Response

    Not Recruiting
  • participants needed
  • sponsor
    Manhattan Medical Research Practice, PLLC
Updated on 22 January 2021


Subjects who have had an incomplete response to previous Xiaflex will receive up to 4 additional cycles of treatment.

Condition Peyronie's Disease
Treatment Xiaflex® 0.58 mg
Clinical Study IdentifierNCT03767452
SponsorManhattan Medical Research Practice, PLLC
Last Modified on22 January 2021

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note